Development of an ELISA Using Polypeptide Fragments of Hemoglobin-Acrylamide Adducts for Biological Monitoring of Acrylamide Exposure
Public Domain
-
2003/09/01
Details
-
Personal Author:
-
Description:Acrylamide (AA), a probable human carcinogen and genotoxicant, is widely used in industry and agriculture. Acrylamide and its metabolite, glycidamide (GA), are known to form hemoglobin (Hb-AA) adducts that can be used as a biomarkers of exposure. Presently, a modified Edman Degradation followed by GC/MS (ED-GC/MS) analysis is used to measure Hb-AAs. Screening large populations for AA exposure with ED-GC/MS is time consuming, labor intensive and expensive. We are developing an Enzyme Linked Immunosorbant Assay (ELISA) technique to evaluate HIJ.AA with a minimum sample preparation and analysis time. Both AA and GA bind to Hb at the N-terminal valine (N-Term-Val) residue. We synthesized AA- and GA-modified-N-Term-Val decapeptides, homologous with both the alpha and beta chain of Hb. Polyclonal anti-AA- and GA-modlified. N-Term-Val decapeptide antibodies are then used in the development of a high throughput competetive direct ELISA to evaluate AA exposure in humans. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0065-7727
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:226
-
NIOSHTIC Number:nn:20031842
-
Citation:Abstr Pap - Am Chem Soc 2003 Sep; 226(Pt 1):U88 033-ARGO
-
Contact Point Address:Cynthia A. F. Striley, Biomonitoring and Health Assessment Branch, CDC/NIOSH, 4676 Columbia Parkway, Mailstop C-26, Cincinnati, OH 45226
-
Email:chs3@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2003
-
Peer Reviewed:False
-
Part Number:1
-
Source Full Name:Abstracts of Papers - American Chemical Society
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e9e1e496f4defd86620f0f057387237a45ca9ad1a5df2ffb1165e99c29e7d8077bc75dd26e6c4670eb3ff41c101c67c5c424d20adc614c4b8ac30824a5b227eb
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like